Prospects for clinical cancer metabolomics using stable isotope tracers.
about
Stable isotope-resolved metabolomics and applications for drug developmentClinical metabolomics: the next stage of clinical biochemistryMetabolic profiling identifies lung tumor responsiveness to erlotinibA novel deconvolution method for modeling UDP-N-acetyl-D-glucosamine biosynthetic pathways based on (13)C mass isotopologue profiles under non-steady-state conditionsStable isotope resolved metabolomics of lung cancer in a SCID mouse modelStable isotope-resolved metabolomics (SIRM) in cancer research with clinical application to nonsmall cell lung cancerStable Isotope Resolved Metabolomics Analysis of Ribonucleotide and RNA Metabolism in Human Lung Cancer Cells.Modeling cancer metabolism on a genome scale.Isotope enhanced approaches in metabolomics.Mathematical modeling of folate metabolism.Hyperpolarized [2-13C]-fructose: a hemiketal DNP substrate for in vivo metabolic imaging.A review of applications of metabolomics in cancer.Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy.NMR metabonomics for mammalian cell metabolism studies.Regulation of mammalian nucleotide metabolism and biosynthesisMalonate as a ROS product is associated with pyruvate carboxylase activity in acute myeloid leukaemia cells.Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences.isoMETLIN: a database for isotope-based metabolomics.
P2860
Q24629149-C83BE8B9-FE05-4471-8396-C953EF5B573DQ26828034-8EDFA1DB-EFF8-496A-8945-CF1ED85A3BE1Q28390457-551FDD0F-3889-4826-B610-4D8A0CC35901Q33917561-78C52E87-CF43-4702-8BE8-0A663CF0D54EQ35030808-DECFAD95-4ACB-4199-A9CE-B4B389E5721CQ35075007-41B303FC-2AED-48B9-BCD7-6F38620E30CCQ35801072-7B2027B2-D7D2-402A-A3F6-C6EB35C6CDCCQ35850350-2FEC601A-637B-4F92-9E85-457EFD60AF59Q36581517-441D8A05-224B-4DBC-A258-848900294F17Q37100917-7049B3EB-7008-4695-A111-82ED0A48145BQ37486490-A87708CB-9C9E-4D06-A91E-F11C4655DBECQ37512830-75F35103-6D2B-48B0-8B68-EC891EF3F791Q37780690-4E118397-1E32-46B3-B7CA-87979691B8F8Q37810162-725A961D-5968-4352-B9DF-79077DB78E29Q38335072-539CC68E-C898-44C2-B60A-1EA383F76225Q38753698-F86D877E-AB01-41A2-8FD6-63010C587ACFQ38756385-22284CDD-A071-4EA4-A631-605B77104E56Q47115538-64DD1930-D886-4B36-B931-D99139F21A74
P2860
Prospects for clinical cancer metabolomics using stable isotope tracers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prospects for clinical cancer metabolomics using stable isotope tracers.
@en
Prospects for clinical cancer metabolomics using stable isotope tracers.
@nl
type
label
Prospects for clinical cancer metabolomics using stable isotope tracers.
@en
Prospects for clinical cancer metabolomics using stable isotope tracers.
@nl
prefLabel
Prospects for clinical cancer metabolomics using stable isotope tracers.
@en
Prospects for clinical cancer metabolomics using stable isotope tracers.
@nl
P2093
P2860
P1476
Prospects for clinical cancer metabolomics using stable isotope tracers.
@en
P2093
Andrew N Lane
Donald M Miller
Jinlian Tan
Michael Bousamra
Richard M Higashi
Teresa W-M Fan
P2860
P304
P356
10.1016/J.YEXMP.2009.01.005
P577
2009-01-20T00:00:00Z